Trastuzumab MMAE

Trastuzumab MMAE
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82928-1 1 mg - - -

3 - 8 business days*

869.00€
BPS-82928-2 5 mg - - -

3 - 8 business days*

1,935.00€
BPS-82928-3 10 mg - - -

3 - 8 business days*

2,972.00€
 
Trastuzumab MMAE is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug... more
Product information "Trastuzumab MMAE"
Trastuzumab MMAE is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab MMAE is composed of a humanized anti-HER2 antibody Trastuzumab, an enzymatically cleavable peptide-linker Valine-citrulline, a tubulin inhibitor Monomethyl auristatin E (MMAE). Trastuzumab MMAE can be used for the research of HER2-positive breast cancer1.
Keywords: Anti-HER2, Anti-CD340, Anti-ERBB2, Anti-MLN 19, Anti-p185erbB2, EC=2.7.10.1, Anti-Proto-oncogene Neu, Anti-Proto-oncogene c-ErbB-2, Anti-Metastatic lymph node gene 19 protein, Anti-Receptor tyrosine-protein kinase erbB-2,
Supplier: BPS Bioscience
Supplier-Nr: 82928

Properties

Application: Cancer therapy target studies
Conjugate: No
Species reactivity: human
Format: Solution

Handling & Safety

Storage: -80°C (protect from light)
Shipping: -80°C (International: -80°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Trastuzumab MMAE"
Write a review
or to review a product.
Viewed